To determine long-term safety and efficacy of pregabalin in patients with partial seizures.

Inclusion Criteria:

• Must have met the inclusion criteria for preceding double-blind study
• Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion Criteria:

• Cannot be pregnant or considering becoming pregnant during the course of the study.
• Cannot be receiving any concomitant medication that could alter the effectiveness of the pregabalin response or affect seizure frequency.